# Virpax Pharmaceuticals, Inc. (VRPX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VRPX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -12.68M | $ -17.57M | $ 0 | $ -913.8K |
| 2023 | $ 0 | $ -16.28M | $ -10.65M | $ 0 | $ 1.93M |
| 2022 | $ 0 | $ -23.97M | $ -19.94M | $ 0 | $ 16.58M |
| 2021 | $ 0 | $ -14.33M | $ -17.29M | $ 0 | $ 37.48M |
| 2020 | $ 0 | $ -5.53M | $ -1.76M | $ 1.57M | $ -4.22M |
| 2019 | $ 0 | $ -4.27M | $ -1.46M | $ 1.26M | $ -2.73M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | -2.70 |
| Current Ratio | 0.63 |

## Other views

- [Metrics](https://sponda.capital/en/VRPX.md)
- [Charts](https://sponda.capital/en/VRPX/charts.md)
- [Compare](https://sponda.capital/en/VRPX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.